AR127176A1 - Polipéptidos de unión a antígeno, complejos de polipéptidos de unión a antígeno y métodos de uso de los mismos - Google Patents
Polipéptidos de unión a antígeno, complejos de polipéptidos de unión a antígeno y métodos de uso de los mismosInfo
- Publication number
- AR127176A1 AR127176A1 ARP220102616A ARP220102616A AR127176A1 AR 127176 A1 AR127176 A1 AR 127176A1 AR P220102616 A ARP220102616 A AR P220102616A AR P220102616 A ARP220102616 A AR P220102616A AR 127176 A1 AR127176 A1 AR 127176A1
- Authority
- AR
- Argentina
- Prior art keywords
- antigen
- polypeptides
- binding
- chain variable
- variable region
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 11
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 11
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 11
- 238000000034 method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 abstract 2
- 101000998953 Homo sapiens Immunoglobulin heavy variable 1-2 Proteins 0.000 abstract 2
- 101001008255 Homo sapiens Immunoglobulin kappa variable 1D-8 Proteins 0.000 abstract 2
- 101001047628 Homo sapiens Immunoglobulin kappa variable 2-29 Proteins 0.000 abstract 2
- 101001008321 Homo sapiens Immunoglobulin kappa variable 2D-26 Proteins 0.000 abstract 2
- 101001047619 Homo sapiens Immunoglobulin kappa variable 3-20 Proteins 0.000 abstract 2
- 101001008263 Homo sapiens Immunoglobulin kappa variable 3D-15 Proteins 0.000 abstract 2
- 102100036887 Immunoglobulin heavy variable 1-2 Human genes 0.000 abstract 2
- 102100022949 Immunoglobulin kappa variable 2-29 Human genes 0.000 abstract 2
- 108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163249722P | 2021-09-29 | 2021-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR127176A1 true AR127176A1 (es) | 2023-12-27 |
Family
ID=85783606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220102616A AR127176A1 (es) | 2021-09-29 | 2022-09-28 | Polipéptidos de unión a antígeno, complejos de polipéptidos de unión a antígeno y métodos de uso de los mismos |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR127176A1 (fr) |
| AU (1) | AU2022357501A1 (fr) |
| CA (1) | CA3232365A1 (fr) |
| IL (1) | IL311762A (fr) |
| TW (1) | TW202325744A (fr) |
| WO (1) | WO2023056315A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116574748B (zh) * | 2023-07-10 | 2023-09-12 | 昆明医科大学 | 一种用于靶向KRAS高频突变肿瘤的嵌合型nTCR-T构建方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013128027A1 (fr) * | 2012-03-01 | 2013-09-06 | Amgen Research (Munich) Gmbh | Molécules de liaison à un polypeptide à longue durée de vie |
| WO2020088631A1 (fr) * | 2018-11-01 | 2020-05-07 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions et procédés pour l'ingénierie des lymphocytes t |
-
2022
- 2022-09-28 WO PCT/US2022/077203 patent/WO2023056315A1/fr active Application Filing
- 2022-09-28 IL IL311762A patent/IL311762A/en unknown
- 2022-09-28 CA CA3232365A patent/CA3232365A1/fr active Pending
- 2022-09-28 TW TW111136760A patent/TW202325744A/zh unknown
- 2022-09-28 AU AU2022357501A patent/AU2022357501A1/en active Pending
- 2022-09-28 AR ARP220102616A patent/AR127176A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023056315A1 (fr) | 2023-04-06 |
| IL311762A (en) | 2024-05-01 |
| TW202325744A (zh) | 2023-07-01 |
| CA3232365A1 (fr) | 2023-04-06 |
| AU2022357501A1 (en) | 2024-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR076797A1 (es) | Anticuerpos triespecificos o tetraespecificos | |
| AR077088A1 (es) | Proteinas biespecificas de union a antigeno | |
| PE20190514A1 (es) | Proteinas de union de tipo anticuerpo biespecificas que se unen especificamente a cd3 y cd123 | |
| JP2018537415A5 (fr) | ||
| RU2016138347A (ru) | Трифункциональная антигенсвязывающая молекула | |
| PE20191463A1 (es) | Anticuerpos biespecificos de union especifica pd1 y lag3 | |
| JP2016536322A5 (fr) | ||
| EA201891322A1 (ru) | Анти-tl1a/анти-tnf-альфа биспецифические антигенсвязывающие белки и их применение | |
| EA201791666A1 (ru) | Антитела к cd3, антитела к cd123 и биспецифические антитела, которые специфически связываются с cd3 и/или cd123 | |
| AR120585A1 (es) | Proteínas de unión a antígenos que se unen específicamente a mage-a | |
| RU2015144098A (ru) | Четырехвалентные биспецифические антитела | |
| AR127176A1 (es) | Polipéptidos de unión a antígeno, complejos de polipéptidos de unión a antígeno y métodos de uso de los mismos | |
| RU2012131671A (ru) | Способ полипептидной модификации для очистки полипептидных мультимеров | |
| AR080793A1 (es) | Anticuerpos biespecificos | |
| AR077111A1 (es) | Proteinas biespecificas tetravalentes de union a antigeno | |
| CL2021000942A1 (es) | Anticuerpos anti-npr1 y usos relacionados. | |
| RU2015152077A (ru) | Тримерные антигенсвязывающие молекулы | |
| RU2018141360A (ru) | Contorsbody - одноцепочечный связывающий мишень агент | |
| MX2022000652A (es) | Anticuerpos contra claudina 18 y metodos de tratamiento del cancer. | |
| CO2023009615A2 (es) | Anticuerpos multiespecíficos que tienen especificidad para il-4r e il-31 | |
| AR123537A1 (es) | Anticuerpo contra hla-dq2.5 y su uso para el tratamiento de la enfermedad celíaca | |
| PE20240761A1 (es) | Proteinas de union a psma y usos de estas | |
| AR127177A1 (es) | Polipéptidos de unión a antígeno, complejos de polipéptidos de unión a antígeno y métodos de uso de los mismos | |
| AR125040A1 (es) | Constructos anti-vista y usos de estos | |
| AR124609A1 (es) | Anticuerpos divididos y métodos de uso |